FibroGen, Inc. (FGEN)

R&D to Revenue

365.17%

Fiscal year · Period ending:

FGEN logo

FGEN R&D to Revenue

Latest reported365.17%
FGEN FY R&D/Revenue (112.57% → 365.17%)
High-resolution chart · PNG

FGEN r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

FibroGen, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
365.1708%
323.0546%
569.3503%
210.8879%
164.4829%
143.4468%
81.5603%
110.7444%
156.3779%
104.2483%
118.3937%
109.5879%
83.8896%
112.5719%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.